Cleared Special

K202837 - GoSpiro (FDA 510(k) Clearance)

Dec 2020
Decision
70d
Days
Class 2
Risk

K202837 is an FDA 510(k) clearance for the GoSpiro. This device is classified as a Spirometer, Diagnostic (Class II - Special Controls, product code BZG).

Submitted by Monitored Therapeutics, Inc. (Dublin, US). The FDA issued a Cleared decision on December 4, 2020, 70 days after receiving the submission on September 25, 2020.

This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 868.1840.

Submission Details

510(k) Number K202837 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 25, 2020
Decision Date December 04, 2020
Days to Decision 70 days
Submission Type Special
Review Panel Anesthesiology (AN)
Summary Summary PDF

Device Classification

Product Code BZG - Spirometer, Diagnostic
Device Class Class II - Special Controls
CFR Regulation 21 CFR 868.1840